6,10-Methano-6H-pyrazino[2,3-h][3]benzazepine, 7,8,9,10-tetrahydro-
| Title | Journal |
|---|---|
| Varenicline promotes endothelial cell migration by lowering vascular endothelial-cadherin levels via the activated α7 nicotinic acetylcholine receptor-mitogen activated protein kinase axis. | Toxicology 20170901 |
| Varenicline enhances oxidized LDL uptake by increasing expression of LOX-1 and CD36 scavenger receptors through α(7) nAChR in macrophages. | Toxicology 20170401 |
| Organic cation transporter variation and response to smoking cessation therapies. | Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco 20141201 |
| Comparative pathophysiology, toxicology, and human cancer risk assessment of pharmaceutical-induced hibernoma. | Toxicology and applied pharmacology 20131215 |
| Effects of nicotinic acetylcholine receptor agonists on cognition in rhesus monkeys with a chronic cocaine self-administration history. | Neuropharmacology 20130101 |
| The effect of smoking cessation pharmacotherapies on pancreatic beta cell function. | Toxicology and applied pharmacology 20121115 |
| Impact of human D398N single nucleotide polymorphism on intracellular calcium response mediated by α3β4α5 nicotinic acetylcholine receptors. | Neuropharmacology 20121101 |
| Chronic sazetidine-A at behaviorally active doses does not increase nicotinic cholinergic receptors in rodent brain. | The Journal of pharmacology and experimental therapeutics 20121101 |
| Strategies to help a smoker who is struggling to quit. | JAMA 20121017 |
| An economic evaluation based on a randomized placebo-controlled trial of varenicline in smokers with cardiovascular disease: results for Belgium, Spain, Portugal, and Italy. | European journal of preventive cardiology 20121001 |
| Varenicline decreases nicotine self-administration and cue-induced reinstatement of nicotine-seeking behaviour in rats when a long pretreatment time is used. | The international journal of neuropsychopharmacology 20121001 |
| Project Impact: a pharmacotherapy pilot trial investigating the abstinence and treatment adherence of Latino light smokers. | Journal of substance abuse treatment 20121001 |
| Varenicline induced psychosis in schizophrenia. | The Australian and New Zealand journal of psychiatry 20121001 |
| Varenicline decreases alcohol consumption in heavy-drinking smokers. | Psychopharmacology 20121001 |
| Effects of 21 days of varenicline versus placebo on smoking behaviors and urges among non-treatment seeking smokers. | Journal of psychopharmacology (Oxford, England) 20121001 |
| Adverse neuropsychiatric events associated with varenicline use in veterans: a case series. | Issues in mental health nursing 20121001 |
| Characteristics of COPD smokers and effectiveness and safety of smoking cessation medications. | Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco 20120901 |
| Adherence to varenicline among African American smokers: an exploratory analysis comparing plasma concentration, pill count, and self-report. | Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco 20120901 |
| Effects of the combination of metyrapone and oxazepam on intravenous nicotine self-administration in rats. | Psychopharmacology 20120901 |
| Impact of varenicline on cue-specific craving assessed in the natural environment among treatment-seeking smokers. | Psychopharmacology 20120901 |
| The effects of varenicline on attention and inhibitory control among treatment-seeking smokers. | Psychopharmacology 20120901 |
| Use of an α3β4 nicotinic acetylcholine receptor subunit concatamer to characterize ganglionic receptor subtypes with specific subunit composition reveals species-specific pharmacologic properties. | Neuropharmacology 20120901 |
| The antinociceptive effects of nicotinic partial agonists varenicline and sazetidine-A in murine acute and tonic pain models. | The Journal of pharmacology and experimental therapeutics 20120901 |
| Comparisons of high-dose and combination nicotine replacement therapy, varenicline, and bupropion for smoking cessation: a systematic review and multiple treatment meta-analysis. | Annals of medicine 20120901 |
| Varenicline for smoking cessation: nausea severity and variation in nicotinic receptor genes. | The pharmacogenomics journal 20120801 |
| Varenicline is a potent partial agonist at α6β2* nicotinic acetylcholine receptors in rat and monkey striatum. | The Journal of pharmacology and experimental therapeutics 20120801 |
| Do package inserts reflect symptoms experienced in practice?: assessment using an automated phone pharmacovigilance system with varenicline and zolpidem in a primary care setting. | Drug safety 20120801 |
| Efficacy and safety of pharmacotherapy for smoking cessation among pregnant smokers: a meta-analysis. | BJOG : an international journal of obstetrics and gynaecology 20120801 |
| Cost-effectiveness of varenicline versus bupropion, nicotine-replacement therapy, and unaided cessation in Greece. | Clinical therapeutics 20120801 |
| Health impact of smoking and smoking cessation strategies: current evidence. | British journal of community nursing 20120801 |
| Does varenicline worsen psychiatric symptoms in patients with schizophrenia or schizoaffective disorder? A review of published studies. | The Journal of clinical psychiatry 20120801 |
| Synthesis and nicotinic acetylcholine receptor in vitro and in vivo pharmacological properties of 2'-fluoro-3'-(substituted phenyl)deschloroepibatidine analogues of 2'-fluoro-3'-(4-nitrophenyl)deschloroepibatidine. | Journal of medicinal chemistry 20120726 |
| Structural characterization of binding mode of smoking cessation drugs to nicotinic acetylcholine receptors through study of ligand complexes with acetylcholine-binding protein. | The Journal of biological chemistry 20120706 |
| Prescribing of nicotine replacement therapy to cardiovascular disease patients in England. | Addiction (Abingdon, England) 20120701 |
| Varenicline increases in vivo striatal dopamine D2/3 receptor binding: an ultra-high-resolution pinhole [123I]IBZM SPECT study in rats. | Nuclear medicine and biology 20120701 |
| Epistaxis and other haemorrhagic events associated with the smoking cessation medicine varenicline: a case series from two national pharmacovigilance centres. | European journal of clinical pharmacology 20120701 |
| Effectiveness of varenicline for smoking cessation at 2 urban academic health centers. | European journal of internal medicine 20120701 |
| Varenicline blocks β2*-nAChR-mediated response and activates β4*-nAChR-mediated responses in mice in vivo. | Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco 20120601 |
| A single administration of low-dose varenicline saturates α4β2* nicotinic acetylcholine receptors in the human brain. | Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20120601 |
| Pharmacologic characterization of a nicotine-discriminative stimulus in rhesus monkeys. | The Journal of pharmacology and experimental therapeutics 20120601 |
| Classification of inhibitors of hepatic organic anion transporting polypeptides (OATPs): influence of protein expression on drug-drug interactions. | Journal of medicinal chemistry 20120524 |
| Synthesis and nicotinic receptor activity of chemical space analogues of N-(3R)-1-azabicyclo[2.2.2]oct-3-yl-4-chlorobenzamide (PNU-282,987) and 1,4-diazabicyclo[3.2.2]nonane-4-carboxylic acid 4-bromophenyl ester (SSR180711). | Journal of medicinal chemistry 20120524 |
| A pilot test of a combined tobacco dependence treatment and lung cancer screening program. | Lung cancer (Amsterdam, Netherlands) 20120501 |
| Very low rate and light smokers: smoking patterns and cessation-related behaviour in England, 2006-11. | Addiction (Abingdon, England) 20120501 |
| Varenicline potentiates alcohol-induced negative subjective responses and offsets impaired eye movements. | Alcoholism, clinical and experimental research 20120501 |
| [Effectiveness and safety of varenicline for smoking cessation]. | Deutsche medizinische Wochenschrift (1946) 20120501 |
| A randomized, double-blind, placebo-controlled study evaluating the safety and efficacy of varenicline for smoking cessation in patients with schizophrenia or schizoaffective disorder. | The Journal of clinical psychiatry 20120501 |
| Nicotine receptor partial agonists for smoking cessation. | The Cochrane database of systematic reviews 20120418 |
| Changes in health-related quality of life with smoking cessation treatment. | European journal of public health 20120401 |
| Plasma levels of metabolites of catecholamine in nicotine-dependent patients treated with varenicline. | Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco 20120401 |
| Efficacy and tolerability of pharmacotherapies to aid smoking cessation in adolescents. | Paediatric drugs 20120401 |
| Promoting smoking cessation. | American family physician 20120315 |
| Cost-effectiveness of tobacco control policies in Vietnam: the case of personal smoking cessation support. | Addiction (Abingdon, England) 20120301 |
| Varenicline dose dependently enhances responding for nonpharmacological reinforcers and attenuates the reinforcement-enhancing effects of nicotine. | Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco 20120301 |
| A randomized placebo-controlled trial of varenicline for smoking cessation allowing flexible quit dates. | Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco 20120301 |
| Smoking cessation after brain damage does not lead to increased depression: implications for understanding the psychiatric complications of varenicline. | Cognitive and behavioral neurology : official journal of the Society for Behavioral and Cognitive Neurology 20120301 |
| A randomized trial of varenicline (Chantix) for the treatment of spinocerebellar ataxia type 3. | Neurology 20120221 |
| Pfizer advertises smoking cessation drug despite health warnings. | CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne 20120207 |
| Varenicline versus bupropion XL for smoking cessation in older adolescents: a randomized, double-blind pilot trial. | Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco 20120201 |
| Results of an initial clinical trial of varenicline for the treatment of cocaine dependence. | Drug and alcohol dependence 20120201 |
| Effects of varenicline and bupropion on cognitive processes among nicotine-deprived smokers. | Experimental and clinical psychopharmacology 20120201 |
| Adjunctive varenicline treatment with antipsychotic medications for cognitive impairments in people with schizophrenia: a randomized double-blind placebo-controlled trial. | Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20120201 |
| Smoking cessation pharmacogenetics: analysis of varenicline and bupropion in placebo-controlled clinical trials. | Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20120201 |
| The effects of extended pre-quit varenicline treatment on smoking behavior and short-term abstinence: a randomized clinical trial. | Clinical pharmacology and therapeutics 20120201 |
| Quitting smoking with varenicline: parallel, randomised efficacy trial in Iran. | The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease 20120201 |
| Grover disease may result from the impairment of keratinocytic cholinergic receptors. | Journal of the American Academy of Dermatology 20120201 |
| Systematic review of the cost-effectiveness of varenicline vs. bupropion for smoking cessation. | International journal of clinical practice 20120201 |
| Cost-effectiveness analysis of varenicline versus existing smoking cessation strategies in Central America and the Caribbean using the BENESCO model. | Hospital practice (1995) 20120201 |
| Cost analysis of varenicline versus bupropion, nicotine replacement therapy, and unaided cessation in Nicaragua. | Hospital practice (1995) 20120201 |
| Varenicline: aggression and homicidal ideation. | Prescrire international 20120201 |
| The pain of giving up smoking. | International journal of cardiology 20120126 |
| Identification of novel α4β2-nicotinic acetylcholine receptor (nAChR) agonists based on an isoxazole ether scaffold that demonstrate antidepressant-like activity. | Journal of medicinal chemistry 20120126 |
| [Smoking cessation in medical practice--new possibilities?]. | Revue medicale suisse 20120125 |
| New reports examine psychiatric risks of varenicline for smoking cessation. | JAMA 20120111 |
| Varenicline as a smoking cessation aid in schizophrenia: effects on smoking behavior and reward sensitivity. | Psychopharmacology 20120101 |
| Safety and tolerability of varenicline tartrate (Champix(®)/Chantix(®)) for smoking cessation in HIV-infected subjects: a pilot open-label study. | AIDS patient care and STDs 20120101 |
| Cardiovascular events in patients taking varenicline: a case series from intensive postmarketing surveillance in New Zealand. | Drug safety 20120101 |
| Varenicline precipitating psychosis in a patient with no previous psychiatric history: a case report of a Spanish patient who was later diagnosed with paranoid personality disorder. | Clinical schizophrenia & related psychoses 20120101 |
| Real world evaluation of three models of NHS smoking cessation service in England. | BMC research notes 20120101 |
| Varenicline in stopping long-term nicotine use. | The American journal on addictions 20120101 |
| Varenicline. | Profiles of drug substances, excipients, and related methodology 20120101 |
| Risk of cardiovascular serious adverse events associated with varenicline use for tobacco cessation: systematic review and meta-analysis. | BMJ (Clinical research ed.) 20120101 |
| Drug-induced liver injury due to varenicline: a case report. | BMC gastroenterology 20120101 |
| Economic impact of delays in listing decisions by provincial drug plans after a positive Common Drug Review recommendation: the case of a smoking-cessation treatment. | Healthcare quarterly (Toronto, Ont.) 20120101 |
| Use of the Patient Health Questionnaire-2 to predict suicidal ideations in patients taking varenicline. | The American journal on addictions 20120101 |
| A novel recruitment message to increase enrollment into a smoking cessation treatment program: preliminary results from a randomized trial. | Health communication 20111201 |
| Effects of moderate-dose treatment with varenicline on neurobiological and cognitive biomarkers in smokers and nonsmokers with schizophrenia or schizoaffective disorder. | Archives of general psychiatry 20111201 |
| Tobacco dependence treatment for hospitalized smokers: a randomized, controlled, pilot trial using varenicline. | Addictive behaviors 20111201 |
| Efficacy of a flexible quit date versus an a priori quit date approach to smoking cessation: a cross-study analysis. | Addictive behaviors 20111201 |
| A cost-effectiveness model of smoking cessation based on a randomised controlled trial of varenicline versus placebo in patients with chronic obstructive pulmonary disease. | Expert opinion on pharmacotherapy 20111201 |
| Translating clinical findings into knowledge in drug safety evaluation--drug induced liver injury prediction system (DILIps). | PLoS computational biology 20111201 |
| [The evaluation of strengthened psychological and behavioral intervention in smoking cessation clinics]. | Zhonghua nei ke za zhi 20111201 |
| Varenicline prevents affective and cognitive exacerbation during smoking abstinence in male patients with schizophrenia. | Psychiatry research 20111130 |
| Quantification of nicotine, cotinine, trans-3'-hydroxycotinine and varenicline in human plasma by a sensitive and specific UPLC-tandem mass-spectrometry procedure for a clinical study on smoking cessation. | Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20111115 |
| Unichiral 2-(2'-pyrrolidinyl)-1,4-benzodioxanes: the 2R,2'S diastereomer of the N-methyl-7-hydroxy analogue is a potent α4β2- and α6β2-nicotinic acetylcholine receptor partial agonist. | Journal of medicinal chemistry 20111110 |
| Varenicline effects on craving, cue reactivity, and smoking reward. | Psychopharmacology 20111101 |
| Lung function and respiratory symptoms in a 1-year randomized smoking cessation trial of varenicline in COPD patients. | Respiratory medicine 20111101 |
| The smoking cessation drug varenicline improves deficient P20-N40 inhibition in DBA/2 mice. | Pharmacology, biochemistry, and behavior 20111101 |
| Effects of varenicline on the reinforcing and discriminative stimulus effects of cocaine in rhesus monkeys. | The Journal of pharmacology and experimental therapeutics 20111101 |
| [Good effect of varenicline in snuff use cessation. Double-blind placebo controlled comparative study]. | Lakartidningen 20111101 |
| The effect of varenicline on heart rate variability in healthy smokers and nonsmokers. | Autonomic neuroscience : basic & clinical 20111028 |
| Cost effectiveness of interventions to reduce relapse to smoking following smoking cessation. | Addiction (Abingdon, England) 20111001 |
| The impact of the introduction of smoke-free legislation on prescribing of stop-smoking medications in England. | Addiction (Abingdon, England) 20111001 |
| Efficacy of varenicline to prompt quit attempts in smokers not currently trying to quit: a randomized placebo-controlled trial. | Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco 20111001 |
| Patterns of nicotinic receptor antagonism: nicotine discrimination studies. | The Journal of pharmacology and experimental therapeutics 20111001 |
| Varenicline is a potent agonist of the human 5-hydroxytryptamine3 receptor. | The Journal of pharmacology and experimental therapeutics 20111001 |
| Observational study of safety and efficacy of varenicline for smoking cessation among Filipino smokers. | Current medical research and opinion 20111001 |
| Nicotine receptor partial agonists for smoking cessation. | American family physician 20111001 |
| More evidence that varenicline harms the heart. | The Harvard mental health letter 20111001 |
| A comparison of brain and behavioral effects of varenicline and nicotine in rats. | Behavioural brain research 20110930 |
| Clinical practice. Treating smokers in the health care setting. | The New England journal of medicine 20110929 |
| Risk of serious adverse cardiovascular events associated with varenicline: a systematic review and meta-analysis. | CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne 20110906 |
| Varenicline for smoking cessation: is it a heartbreaker? | CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne 20110906 |
| Varenicline: quantifying the risk. | CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne 20110906 |
| Varenicline: quantifying the risk. | CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne 20110906 |
| Varenicline: quantifying the risk. | CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne 20110906 |
| Varenicline: quantifying the risk. | CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne 20110906 |
| Varenicline: quantifying the risk. | CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne 20110906 |
| Varenicline: cardiovascular safety. | CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne 20110906 |
| [Abstinence rates with varenicline compared to bupropion and nicotine replacement therapy for quitting smoking in primary care]. | Atencion primaria 20110901 |
| Dissociation between duration of action in the forced swim test in mice and nicotinic acetylcholine receptor occupancy with sazetidine, varenicline, and 5-I-A85380. | Psychopharmacology 20110901 |
| A pilot clinical trial of varenicline for smoking cessation in black smokers. | Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco 20110901 |
| A pilot study of the efficacy of varenicline for the treatment of smokeless tobacco users in Midwestern United States. | Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco 20110901 |
| Did the introduction of varenicline in England substitute for or add to the use of other smoking cessation medications? | Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco 20110901 |
| Psychiatric adverse events associated with varenicline: an intensive postmarketing prospective cohort study in New Zealand. | Drug safety 20110901 |
| In brief: Cardiovascular safety of varenicline (Chantix). | The Medical letter on drugs and therapeutics 20110822 |
| Varenicline for tobacco dependence: panacea or plight? | Expert opinion on pharmacotherapy 20110801 |
| [Clinical study of smoking cessation clinic subjects]. | Nihon Jibiinkoka Gakkai kaiho 20110801 |
| Varenicline attenuates cue-induced relapse to alcohol, but not nicotine seeking, while reducing inhibitory response control. | Psychopharmacology 20110701 |
| Effectiveness of varenicline for smoking cessation: a 1-year follow-up study. | Journal of substance abuse treatment 20110701 |
| Varenicline, a partial agonist at neuronal nicotinic acetylcholine receptors, reduces nicotine-induced increases in 20% ethanol operant self-administration in Sprague-Dawley rats. | Addiction biology 20110701 |
| Prescribing of smoking cessation medication in England since the introduction of varenicline. | Addiction (Abingdon, England) 20110701 |
| The sensitizing effect of acute nicotine on amphetamine-stimulated behavior and dopamine efflux requires activation of β2 subunit-containing nicotinic acetylcholine receptors and glutamate N-methyl-D-aspartate receptors. | Neuropharmacology 20110601 |
| A preliminary investigation of varenicline for heavy drinking smokers. | Psychopharmacology 20110601 |
| A double-blind randomized placebo-controlled pilot study of neuropsychiatric adverse events in abstinent smokers treated with varenicline or placebo. | Biological psychiatry 20110601 |
| Selective α4β2 nicotinic acetylcholine receptor agonists target epigenetic mechanisms in cortical GABAergic neurons. | Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20110601 |
| Varenicline for smoking cessation in people with schizophrenia: a double blind randomized pilot study. | Schizophrenia research 20110601 |
| Varenicline induced mania in a 51 year old patient without history of bipolar illness. | Progress in neuro-psychopharmacology & biological psychiatry 20110601 |
| A discrete-event simulation of smoking-cessation strategies based on varenicline pivotal trial data. | PharmacoEconomics 20110601 |
| A case of late-life onset mania during Varenicline assisted smoking cessation. | International journal of geriatric psychiatry 20110601 |
| A smoking cessation intervention for thoracic surgery and oncology clinics: a pilot trial. | Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 20110601 |
| Varenicline and the evaluation of neuropsychiatric adverse events in smokers. | Biological psychiatry 20110601 |
| Core modification of cytisine: a modular synthesis. | Angewandte Chemie (International ed. in English) 20110523 |
| Effects of varenicline on smoking cue–triggered neural and craving responses. | Archives of general psychiatry 20110501 |
| Nicotinic receptor agonists decrease L-dopa-induced dyskinesias most effectively in partially lesioned parkinsonian rats. | Neuropharmacology 20110501 |
| Electrophysiological perspectives on the therapeutic use of nicotinic acetylcholine receptor partial agonists. | The Journal of pharmacology and experimental therapeutics 20110501 |
| Utilization of services in a randomized trial testing phone- and web-based interventions for smoking cessation. | Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco 20110501 |
| Adherence to varenicline in the COMPASS smoking cessation intervention trial. | Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco 20110501 |
| Treatment of nicotine dependence with Chantix (varenicline). | Texas dental journal 20110501 |
| Use of varenicline for 4 weeks before quitting smoking: decrease in ad lib smoking and increase in smoking cessation rates. | Archives of internal medicine 20110425 |
| Smoking cessation interventions: a primer for physicians: Comment on 'Use of varenicline for 4 weeks before quitting smoking'. | Archives of internal medicine 20110425 |
| [Smoking cessation--assistance for the general practitioner]. | MMW Fortschritte der Medizin 20110407 |
| Pharmacokinetics, safety, and tolerability following multiple oral doses of varenicline under various titration schedules in elderly nonsmokers. | Journal of clinical pharmacology 20110401 |
| Single- and multiple-dose pharmacokinetics of the selective nicotinic receptor partial agonist, varenicline, in healthy Japanese adult smokers. | Journal of clinical pharmacology 20110401 |
| A review of cost-effectiveness of varenicline and comparison of cost-effectiveness of treatments for major smoking-related morbidities. | Journal of evaluation in clinical practice 20110401 |
| Effectiveness of varenicline as an aid to smoking cessation: results of an inter-European observational study. | Current medical research and opinion 20110401 |
| What justifies a placebo-controlled trial of Varenicline for smoking cessation in patients with COPD? | Chest 20110401 |
| Effects of varenicline in adult smokers: a multinational, 24-week, randomized, double-blind, placebo-controlled study. | Clinical therapeutics 20110401 |
| Smoking cessation pharmacotherapy: a concise overview. | Advance for NPs & PAs 20110401 |
| Breaking free from nicotine dependence. A combination of strategies boosts the odds of success. | The Harvard mental health letter 20110401 |
| Clinical shorts. | CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne 20110322 |
| Effects of varenicline on smoking cessation in patients with mild to moderate COPD: a randomized controlled trial. | Chest 20110301 |
| Abstinence and psychological distress in co-morbid smokers using various pharmacotherapies. | Drug and alcohol dependence 20110301 |
| The effects of nicotine, varenicline, and cytisine on schedule-controlled responding in mice: differences in α4β2 nicotinic receptor activation. | European journal of pharmacology 20110301 |
| Nicotine dependence: health consequences, smoking cessation therapies, and pharmacotherapy. | Primary care 20110301 |
| Interventions for smokeless tobacco use cessation. | The Cochrane database of systematic reviews 20110216 |
| Nicotine receptor partial agonists for smoking cessation. | The Cochrane database of systematic reviews 20110216 |
| Varenicline blocks nicotine intake in rats with extended access to nicotine self-administration. | Psychopharmacology 20110201 |
| Dose-dependent and sustained effects of varenicline on dopamine D2/3 receptor availability in rats. | European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 20110201 |
| Adherence to and reasons for premature discontinuation from stop-smoking medications: data from the ITC Four-Country Survey. | Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco 20110201 |
| Australia's experience with varenicline: usage, costs and adverse reactions. | Addiction (Abingdon, England) 20110201 |
| Adynamic ileus induced by varenicline. | Current drug safety 20110201 |
| Integrating results from smoking cessation drug research and development into clinical occupational health practice. | AAOHN journal : official journal of the American Association of Occupational Health Nurses 20110201 |
| Effects of copayment on initiation of smoking cessation pharmacotherapy: an analysis of varenicline reversed claims. | Clinical therapeutics 20110201 |
| [Pharmacotherapies for nicotine dependence: review of scientific evidence. Spanish Society of Smoking Specialists: recommendations about election and individualization]. | Medicina clinica 20110129 |
| Varenicline for tobacco dependence treatment in recovering alcohol-dependent smokers: an open-label pilot study. | Journal of substance abuse treatment 20110101 |
| Effect of co-administration of varenicline and antidepressants on extracellular monoamine concentrations in rat prefrontal cortex. | Neurochemistry international 20110101 |
| Parallel anxiolytic-like effects and upregulation of neuronal nicotinic acetylcholine receptors following chronic nicotine and varenicline. | Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco 20110101 |
| Impact of genetic variability in nicotinic acetylcholine receptors on nicotine addiction and smoking cessation treatment. | Current medicinal chemistry 20110101 |
| Functional interactions of fibrillar and oligomeric amyloid-β with alpha7 nicotinic receptors in Alzheimer's disease. | Journal of Alzheimer's disease : JAD 20110101 |
| Counselors' knowledge of the adoption of tobacco cessation medications in substance abuse treatment programs. | The American journal on addictions 20110101 |
| Nicotinic acetylcholine receptors containing the α4 subunit are critical for the nicotine-induced reduction of acute voluntary ethanol consumption. | Channels (Austin, Tex.) 20110101 |
| Pharmacotherapy for smoking. | Canadian family physician Medecin de famille canadien 20110101 |
| Usage patterns of stop smoking medications in Australia, Canada, the United Kingdom, and the United States: findings from the 2006-2008 International Tobacco Control (ITC) Four Country Survey. | International journal of environmental research and public health 20110101 |
| Correlation between willing to smoking cessation and treatment outcome of health care workers in Thailandt. | Journal of the Medical Association of Thailand = Chotmaihet thangphaet 20110101 |
| Pharmacotherapy for smoking cessation: present and future. | Current pharmaceutical design 20110101 |
| Culturally-tailored smoking cessation for American Indians: study protocol for a randomized controlled trial. | Trials 20110101 |
| A manic episode in a 64-year-old man: an adverse effect of varenicline. | General hospital psychiatry 20110101 |
| The management of tobacco smoking. | Cardiovascular journal of Africa 20110101 |
| Varenicline induces manic relapse in bipolar disorder. | General hospital psychiatry 20110101 |
| Gastrointestinal adverse effects of varenicline at maintenance dose: a meta-analysis. | BMC clinical pharmacology 20110101 |
| Suicidal behavior and depression in smoking cessation treatments. | PloS one 20110101 |
| Effects of smoking cessation on central blood pressure and arterial stiffness. | Vascular health and risk management 20110101 |
| Adverse effects and tolerability of medications for the treatment of tobacco use and dependence. | Drugs 20101224 |
| Nicotine receptor partial agonists for smoking cessation. | The Cochrane database of systematic reviews 20101208 |
| Drug treatment for users of smokeless tobacco. | BMJ (Clinical research ed.) 20101206 |
| The high-affinity nAChR partial agonists varenicline and sazetidine-A exhibit reinforcing properties in rats. | Progress in neuro-psychopharmacology & biological psychiatry 20101201 |
| Drug discrimination in methamphetamine-trained rats: effects of cholinergic nicotinic compounds. | The Journal of pharmacology and experimental therapeutics 20101201 |
| The nicotinic acetylcholine receptor partial agonist varenicline increases the ataxic and sedative-hypnotic effects of acute ethanol administration in C57BL/6J mice. | Alcoholism, clinical and experimental research 20101201 |
| Nicotine receptors and depression: revisiting and revising the cholinergic hypothesis. | Trends in pharmacological sciences 20101201 |
| A review of the clinical pharmacokinetics and pharmacodynamics of varenicline for smoking cessation. | Clinical pharmacokinetics 20101201 |
| Varenicline-induced grand mal seizure. | Epileptic disorders : international epilepsy journal with videotape 20101201 |
| Thiopurine S-methyltransferase deficiency associated with a novel mutation. | Inflammatory bowel diseases 20101101 |
| Immediate versus delayed quitting and rates of relapse among smokers treated successfully with varenicline, bupropion SR or placebo. | Addiction (Abingdon, England) 20101101 |
| Mental health stability in veterans with posttraumatic stress disorder receiving varenicline. | American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20101101 |
| [Sustainable efficacy of oral varenicline for smoking cessation]. | Nihon Kokyuki Gakkai zasshi = the journal of the Japanese Respiratory Society 20101101 |
| Comparison of available treatments for tobacco addiction. | Current psychiatry reports 20101001 |
| A pilot study to assess smokeless tobacco use reduction with varenicline. | Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco 20101001 |
| Nicotine gum dependence treated with varenicline--a case report. | Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco 20101001 |
| Clinical experience of varenicline for smoking cessation. | The clinical respiratory journal 20101001 |
| A brief review of pharmacotherapeutic treatment options in smoking cessation: bupropion versus varenicline. | Journal of the American Academy of Nurse Practitioners 20101001 |
| Relapse prevention in UK Stop Smoking Services: current practice, systematic reviews of effectiveness and cost-effectiveness analysis. | Health technology assessment (Winchester, England) 20101001 |
| Varenicline (champix)-associated manic relapse in bipolar affective disorder. | Irish medical journal 20101001 |
| Utilization of the smoking cessation medicine varenicline: an intensive post-marketing study in New Zealand. | Pharmacoepidemiology and drug safety 20100901 |
| Thoughts and acts of aggression/violence toward others reported in association with varenicline. | The Annals of pharmacotherapy 20100901 |
| Varenicline treatment for smoking cessation in Asian populations: a pooled analysis of placebo-controlled trials conducted in six Asian countries. | Current medical research and opinion 20100901 |
| The safety and efficacy of varenicline in cocaine using smokers maintained on methadone: a pilot study. | The American journal on addictions 20100901 |
| Pharmacoeconomic spotlight on varenicline as an aid to smoking cessation. | CNS drugs 20100901 |
| Utilization management for smoking cessation pharmacotherapy: varenicline rejected claims analysis. | The American journal of managed care 20100901 |
| Electroconvulsive therapy (ECT) effective for psychotic recrudescence and suicidality after varenicline adjunctive therapy for smoking cessation in a schizoaffective patient. | Revista brasileira de psiquiatria (Sao Paulo, Brazil : 1999) 20100901 |
| Letter by Smolderen and Pelle regarding article, 'Efficacy and safety of varenicline for smoking cessation in patients with cardiovascular disease: a randomized trial'. | Circulation 20100831 |
| Drug safety crackdown revs up. | Nature 20100805 |
| Nicotinic partial agonists varenicline and sazetidine-A have differential effects on affective behavior. | The Journal of pharmacology and experimental therapeutics 20100801 |
| Varenicline and mecamylamine attenuate locomotor sensitization and cross-sensitization induced by nicotine and morphine in mice. | Pharmacology, biochemistry, and behavior 20100801 |
| Smoking cessation-recent advances. | Cardiovascular drugs and therapy 20100801 |
| The use of snus for quitting smoking compared with medicinal products. | Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco 20100801 |
| [The management of patients with nicotine dependence - the role of the general practitioners]. | Therapeutische Umschau. Revue therapeutique 20100801 |
| [Medical therapy for smoking cessation]. | Therapeutische Umschau. Revue therapeutique 20100801 |
| [Preventive relapse treatment for tobacco cessation - is it worthwhile?]. | Therapeutische Umschau. Revue therapeutique 20100801 |
| Activation of alpha4* nAChRs is necessary and sufficient for varenicline-induced reduction of alcohol consumption. | The Journal of neuroscience : the official journal of the Society for Neuroscience 20100728 |
| Cross-validation of a new procedure for early screening of smoking cessation medications in humans. | Clinical pharmacology and therapeutics 20100701 |
| Varenicline-induced drug eruption with resulting palmar/plantar hyperhidrosis and dysesthesia. | Journal of the American Academy of Dermatology 20100701 |
| Predictors of post-treatment relapse to smoking in successful quitters: pooled data from two phase III varenicline trials. | Drug and alcohol dependence 20100601 |
| Varenicline induced polydipsia and hyponatremia in a patient with schizophrenia. | Schizophrenia research 20100601 |
| Extinction with varenicline and nornicotine, but not ABT-418, weakens conditioned responding evoked by the interoceptive stimulus effects of nicotine. | Neuropharmacology 20100601 |
| Varenicline treatment decreases DNMT1 mRNA expression in lymphocytes of schizophrenic patients who are cigarette smokers. | Schizophrenia research 20100601 |
| Smoking outcome by psychiatric history after behavioral and varenicline treatment. | Journal of substance abuse treatment 20100601 |
| Characteristics and abstinence outcomes among tobacco quitline enrollees using varenicline or nicotine replacement therapy. | Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco 20100601 |
| Mouse model predicts effects of smoking and varenicline on event-related potentials in humans. | Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco 20100601 |
| Adherence to treatment for tobacco dependence: association with smoking abstinence and predictors of adherence. | Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco 20100601 |
| Varenicline withdrawal-induced delirium with psychosis. | The American journal of psychiatry 20100601 |
| Varenicline in smoking cessation. | Expert review of respiratory medicine 20100601 |
| Activation and inhibition of mouse muscle and neuronal nicotinic acetylcholine receptors expressed in Xenopus oocytes. | The Journal of pharmacology and experimental therapeutics 20100501 |
| Varenicline use in patients with mental illness: an update of the evidence. | Expert opinion on drug safety 20100501 |
| Varenicline's effects on acute smoking behavior and reward and their association with subsequent abstinence. | Psychopharmacology 20100501 |
| Pre-clinical properties of the alpha4beta2 nicotinic acetylcholine receptor partial agonists varenicline, cytisine and dianicline translate to clinical efficacy for nicotine dependence. | British journal of pharmacology 20100501 |
| Behavioral counseling and varenicline treatment for smoking cessation. | American journal of preventive medicine 20100501 |
| [Pharmacological profile and clinical findings on varenicline tartrate (Champix tablets)]. | Nihon yakurigaku zasshi. Folia pharmacologica Japonica 20100501 |
| Effects of the alpha4beta2 partial agonist varenicline on brain activity and working memory in abstinent smokers. | Biological psychiatry 20100415 |
| Evaluation of varenicline as an aid to smoking cessation in UK general practice - a THIN database study. | Current medical research and opinion 20100401 |
| A randomized controlled open comparative trial of varenicline vs nicotine patch in adult smokers: efficacy, safety and withdrawal symptoms (the VN-SEESAW study). | Circulation journal : official journal of the Japanese Circulation Society 20100401 |
| Effects of varenicline and mecamylamine on the acquisition, expression, and reinstatement of nicotine-conditioned place preference by drug priming in rats. | Naunyn-Schmiedeberg's archives of pharmacology 20100401 |
| Psychiatric adverse events in randomized, double-blind, placebo-controlled clinical trials of varenicline: a pooled analysis. | Drug safety 20100401 |
| Varenicline does not increase serum BDNF levels in patients with nicotine dependence. | Human psychopharmacology 20100401 |
| Synthesis, nicotinic acetylcholine receptor binding, and antinociceptive properties of 3'-(substituted phenyl)epibatidine analogues. Nicotinic partial agonists. | Journal of natural products 20100326 |
| Varenicline and pheochromocytoma. | Annals of internal medicine 20100302 |
| Cost effectiveness of varenicline versus bupropion and unaided cessation for smoking cessation in a cohort of Finnish adult smokers. | Current medical research and opinion 20100301 |
| Modulation of ethanol consumption by genetic and pharmacological manipulation of nicotinic acetylcholine receptors in mice. | Psychopharmacology 20100301 |
| Varenicline effects on cocaine self administration and reinstatement behavior. | Behavioural pharmacology 20100301 |
| Quantitative assessment of exposure-response relationships for the efficacy and tolerability of varenicline for smoking cessation. | Clinical pharmacology and therapeutics 20100301 |
| Neuronal nicotinic acetylcholine receptors as pharmacotherapeutic targets for the treatment of alcohol use disorders. | CNS & neurological disorders drug targets 20100301 |
| Smoking cessation intervention: an evidence-based approach. | Postgraduate medicine 20100301 |
| Integrating smoking cessation into HIV care. | AIDS patient care and STDs 20100301 |
| Rapid and sustained response to a single dose of sertraline in a patient with newly emergent depression during varenicline-assisted smoking cessation. | CNS spectrums 20100301 |
| Effect of the alpha4beta2* nicotinic acetylcholine receptor partial agonist varenicline on dopamine release in beta2 knock-out mice with selective re-expression of the beta2 subunit in the ventral tegmental area. | Neuropharmacology 20100201 |
| The nicotinic acetylcholine receptor partial agonist varenicline and the treatment of drug dependence: a review. | European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 20100201 |
| The alpha4beta2 nicotinic acetylcholine-receptor partial agonist varenicline inhibits both nicotine self-administration following repeated dosing and reinstatement of nicotine seeking in rats. | Psychopharmacology 20100201 |
| Current approaches to pharmacotherapy for smoking cessation. | Therapeutic advances in respiratory disease 20100201 |
| Improving the effectiveness of tobacco use cessation (TUC). | International dental journal 20100201 |
| Current treatment options in smoking cessation. | Hospital practice (1995) 20100201 |
| Varenicline and P50 auditory gating in medicated schizophrenic patients: a pilot study. | Psychiatry research 20100130 |
| Varenicline for smoking cessation in patients with coronary heart disease. | Circulation 20100119 |
| Efficacy and safety of varenicline for smoking cessation in patients with cardiovascular disease: a randomized trial. | Circulation 20100119 |
| Pharmacogenetics of smoking cessation therapy. | American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics 20100105 |
| Working memory deficits predict short-term smoking resumption following brief abstinence. | Drug and alcohol dependence 20100101 |
| [Tolerability profile of varenicline in current medical practice]. | Presse medicale (Paris, France : 1983) 20100101 |
| Crossing borders: factors affecting differences in cost-effectiveness of smoking cessation interventions between European countries. | Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research 20100101 |
| The cost-effectiveness of an extended course (12+12 weeks) of varenicline compared with other available smoking cessation strategies in the United States: an extension and update to the BENESCO model. | Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research 20100101 |
| Varenicline: a pharmacoeconomic review of its use as an aid to smoking cessation. | PharmacoEconomics 20100101 |
| [Medications for smoking cessation. New advice concerning important neuropsychiatric effects]. | Perspective infirmiere : revue officielle de l'Ordre des infirmieres et infirmiers du Quebec 20100101 |
| Varenicline for smokeless tobacco dependence. | Journal of postgraduate medicine 20100101 |
| [More or less smoked news]. | Pneumologia (Bucharest, Romania) 20100101 |
| Stopping smokeless tobacco with varenicline: randomised double blind placebo controlled trial. | BMJ (Clinical research ed.) 20100101 |
| Prescription drugs associated with reports of violence towards others. | PloS one 20100101 |
| Smoking cessation in patients with chronic kidney disease. | CANNT journal = Journal ACITN 20100101 |
| Varenicline and suicide. Safety data from New Zealand. | BMJ (Clinical research ed.) 20091231 |
| Cost-effectiveness of varenicline compared with nicotine patches for smoking cessation--results from four European countries. | European journal of public health 20091201 |
| Sibutramine for weight gain attenuation during smoking cessation with varenicline: a pilot study. | Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco 20091201 |
| A retrospective poison center review of varenicline-exposed patients. | The Annals of pharmacotherapy 20091201 |
| Varenicline and antiretroviral therapy in patients with HIV. | Journal of acquired immune deficiency syndromes (1999) 20091201 |
| Varenicline and suicide. Risk of psychiatric side effects with varenicline. | BMJ (Clinical research ed.) 20091201 |
| Smoking cessation agents and suicide. | BMJ (Clinical research ed.) 20091105 |
| Varenicline attenuates some of the subjective and physiological effects of intravenous nicotine in humans. | Psychopharmacology 20091101 |
| What do we know about the role of pharmacotherapy for smoking cessation before or during pregnancy? | Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco 20091101 |
| [Drug treatment of tobacco dependence]. | Deutsche medizinische Wochenschrift (1946) 20091101 |
| Population pharmacokinetic analysis of varenicline in adult smokers. | British journal of clinical pharmacology 20091101 |
| Nicotine dependence and smoking cessation. | Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences 20091101 |
| Varenicline-induced acute generalized exanthematous pustulosis. | Clinical and experimental dermatology 20091001 |
| Preclinical pharmacology of the alpha4beta2 nAChR partial agonist varenicline related to effects on reward, mood and cognition. | Biochemical pharmacology 20091001 |
| Smoking cessation: how to advise the patient. | Heart (British Cardiac Society) 20091001 |
| Acute generalized exanthematous pustulosis caused by varenicline. | Journal of the European Academy of Dermatology and Venereology : JEADV 20090901 |
| Acute hepatic injury associated with varenicline in a patient with underlying liver disease. | The Annals of pharmacotherapy 20090901 |
| Varenicline increases striatal dopamine D(2/3) receptor binding in rats. | Addiction biology 20090901 |
| Varenicline in prevention of relapse to smoking: effect of quit pattern on response to extended treatment. | Addiction (Abingdon, England) 20090901 |
| Lambert-Eaton myasthenic syndrome following varenicline (Chantix) use. | Muscle & nerve 20090901 |
| Varenicline in the management of smoking cessation: a single technology appraisal. | Health technology assessment (Winchester, England) 20090901 |
| Varenicline gets stronger warnings about psychiatric problems, vehicle crashes. | JAMA 20090826 |
| Safety of smoking cessation drugs. | The Medical letter on drugs and therapeutics 20090824 |
| Are nicotine replacement therapy, varenicline or bupropion options for pregnant mothers to quit smoking? Effects on the respiratory system of the offspring. | Therapeutic advances in respiratory disease 20090801 |
| Varenicline reduces alcohol self-administration in heavy-drinking smokers. | Biological psychiatry 20090715 |
| Varenicline: a novel pharmacotherapy for smoking cessation. | Drugs 20090709 |
| Varenicline augmentation in depressed smokers: an 8-week, open-label study. | The Journal of clinical psychiatry 20090701 |
| Tobacco dependence and withdrawal: science base, challenges and opportunities for pharmacotherapy. | Pharmacology & therapeutics 20090701 |
| Varenicline attenuates nicotine-enhanced brain-stimulation reward by activation of alpha4beta2 nicotinic receptors in rats. | Neuropharmacology 20090701 |
| Worsening psychosis induced by varenicline in a hospitalized psychiatric patient. | Pharmacotherapy 20090701 |
| Varenicline overdose in a teenager--a clinical pharmacology perspective. | Clinical toxicology (Philadelphia, Pa.) 20090701 |
| Varenicline-induced mixed mood and psychotic episode in a patient with Schizoaffective Disorder. | CNS spectrums 20090701 |
| Impact of symptoms experienced by varenicline users on tobacco treatment in a real world setting. | Journal of substance abuse treatment 20090601 |
| Does varenicline induce acute interstitial nephritis? | Mayo Clinic proceedings 20090601 |
| Varenicline and proximal myopathy. | The Medical journal of Australia 20090601 |
| Tobacco use among individuals with intellectual or developmental disabilities: a brief review. | Intellectual and developmental disabilities 20090601 |
| Subjective improvement in proprioception in 2 patients with atypical Friedreich ataxia treated with varenicline (Chantix). | Journal of clinical neuromuscular disease 20090601 |
| [Current and future medical drugs for smoking cessation]. | Laryngo- rhino- otologie 20090601 |
| Cost-effectiveness of varenicline for smoking cessation. | Expert review of pharmacoeconomics & outcomes research 20090601 |
| Smoking-cessation therapy using varenicline: the cost-utility of an additional 12-week course of varenicline for the maintenance of smoking abstinence. | Journal of evaluation in clinical practice 20090601 |
| Varenicline reduced smoking behaviour in a mentally ill person. | Journal of psychopharmacology (Oxford, England) 20090501 |
| Persistent genital arousal disorder: a case report in a woman with lifelong PGAD where serendipitous administration of varenicline tartrate resulted in symptomatic improvement. | The journal of sexual medicine 20090501 |
| Mood, side-effects and smoking outcomes among persons with and without probable lifetime depression taking varenicline. | Journal of general internal medicine 20090501 |
| Cognitive and antismoking effects of varenicline in patients with schizophrenia or schizoaffective disorder. | Schizophrenia research 20090501 |
| Combination treatment with varenicline and nicotine replacement therapy. | Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco 20090501 |
| Safety and effectiveness of varenicline in a veteran population with a high prevalence of mental illness. | The Annals of pharmacotherapy 20090501 |
| Hallucinations in the context of varenicline withdrawal. | The American journal of psychiatry 20090501 |
| Reduced affective symptoms during tobacco dependence treatment with varenicline. | Addiction (Abingdon, England) 20090501 |
| Do the 10 UK suicides among those taking the smoking cessation drug varenicline suggest a causal link? | Addiction (Abingdon, England) 20090501 |
| Treatment of comorbid tobacco use in people with serious mental illness. | Journal of psychiatry & neuroscience : JPN 20090501 |
| Chantix-induced mental status changes in a young healthy female. | South Dakota medicine : the journal of the South Dakota State Medical Association 20090501 |
| Findings on alcohol dependence point to promising avenues for targeted therapies. | JAMA 20090422 |
| The relevance and treatment of cue-induced cravings in tobacco dependence. | Journal of substance abuse treatment 20090401 |
| The smoking cessation medication varenicline attenuates alcohol and nicotine interactions in the rat mesolimbic dopamine system. | The Journal of pharmacology and experimental therapeutics 20090401 |
| Smoking in pregnancy and lactation: a review of risks and cessation strategies. | European journal of clinical pharmacology 20090401 |
| Varenicline for smoking cessation: a placebo-controlled, randomized study. | Respirology (Carlton, Vic.) 20090401 |
| Varenicline overdose in a teenager. | Clinical toxicology (Philadelphia, Pa.) 20090401 |
| The pharmacokinetic and tolerability profile of varenicline in healthy Chinese volunteers. | International journal of clinical pharmacology and therapeutics 20090401 |
| Two recent updates for psychiatric conditions. | Journal of child and adolescent psychopharmacology 20090401 |
| Update on smoking cessation therapies. | Advances in therapy 20090401 |
| Real world study to evaluate the effectiveness of varenicline and cognitive-behavioural interventions for smoking cessation. | International journal of environmental research and public health 20090401 |
| Smoking cessation: aspects of prevention and therapy. The activity of the Smoking Cessation Center of Parma-Italy. | Acta bio-medica : Atenei Parmensis 20090401 |
| Studies linking smoking-cessation drug with suicide risk spark concerns. | JAMA 20090311 |
| Varenicline has antidepressant-like activity in the forced swim test and augments sertraline's effect. | European journal of pharmacology 20090301 |
| Smoking cessation with varenicline: a suicidal fatality. | Journal of analytical toxicology 20090301 |
| Varenicline and bupropion sustained-release combination therapy for smoking cessation. | Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco 20090301 |
| Emerging drugs for the treatment of tobacco dependence. | Expert opinion on emerging drugs 20090301 |
| Varenicline: a first-line treatment option for smoking cessation. | Clinical therapeutics 20090301 |
| Antismoking drug still recommended to Canadians despite side effects and US advisory. | CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne 20090217 |
| Varenicline for tobacco dependence. | The New England journal of medicine 20090212 |
| Varenicline for tobacco dependence. | The New England journal of medicine 20090212 |
| A 51-year-old woman with bipolar disorder who wants to quit smoking. | JAMA 20090204 |
| Treatment of imbalance with varenicline Chantix(R): report of a patient with fragile X tremor/ataxia syndrome. | Acta neurologica Scandinavica 20090201 |
| An algorithm for tailoring pharmacotherapy for smoking cessation: results from a Delphi panel of international experts. | Tobacco control 20090201 |
| Interventions for preventing weight gain after smoking cessation. | The Cochrane database of systematic reviews 20090121 |
| Varenicline improves mood and cognition during smoking abstinence. | Biological psychiatry 20090115 |
| Budgetary impact of varenicline in smoking cessation in the United Kingdom. | Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research 20090101 |
| Effects of the nicotinic receptor partial agonists varenicline and cytisine on the discriminative stimulus effects of nicotine in rats. | Pharmacology, biochemistry, and behavior 20090101 |
| Pharmacology of nicotine: addiction, smoking-induced disease, and therapeutics. | Annual review of pharmacology and toxicology 20090101 |
| [Modern medical support for smoking cessation]. | Der Internist 20090101 |
| Update in new medications for primary care. | Journal of general internal medicine 20090101 |
| Targeting reward-relevant nicotinic receptors in the discovery of novel pharmacotherapeutic agents to treat tobacco dependence. | Nebraska Symposium on Motivation. Nebraska Symposium on Motivation 20090101 |
| New findings on nicotine addiction and treatment. | Nebraska Symposium on Motivation. Nebraska Symposium on Motivation 20090101 |
| Quitting smoking without a psychotic break: the potential link between nicotinic acetylcholine receptor partial agonists and neuropsychiatric adverse events. | Clinical nurse specialist CNS 20090101 |
| Do implementation issues influence the effectiveness of medications? The case of nicotine replacement therapy and bupropion in UK Stop Smoking Services. | BMC public health 20090101 |
| [Varenicline - pharmacological therapy of tobacco dependence]. | Wiener medizinische Wochenschrift (1946) 20090101 |
| A preliminary benefit-risk assessment of varenicline in smoking cessation. | Drug safety 20090101 |
| Pharmacokinetics, safety, and tolerability of varenicline in healthy adolescent smokers: a multicenter, randomized, double-blind, placebo-controlled, parallel-group study. | Clinical therapeutics 20090101 |
| Cost-utility analysis of varenicline, an oral smoking-cessation drug, in Japan. | PharmacoEconomics 20090101 |
| Successful smoking cessation and improvement of negative symptoms with varenicline in a stable schizophrenia patient. | The Journal of neuropsychiatry and clinical neurosciences 20090101 |
| Smoking and chronic obstructive pulmonary disease (COPD). Parallel epidemics of the 21 century. | International journal of environmental research and public health 20090101 |
| Safety and drug utilization profile of varenicline as used in general practice in England: interim results from a prescription-event monitoring study. | Drug safety 20090101 |
| Varenicline-induced mania in a bipolar patient. | Clinical neuropharmacology 20090101 |
| [Cardiac arrest with varenicline: a case report]. | Therapie 20090101 |
| Treating tobacco dependence in a medical setting. | CA: a cancer journal for clinicians 20090101 |
| Cost effectiveness of varenicline in Belgium, compared with bupropion, nicotine replacement therapy, brief counselling and unaided smoking cessation: a BENESCO Markov cost-effectiveness analysis. | Clinical drug investigation 20090101 |
| Varenicline and suicidal behaviour: a cohort study based on data from the General Practice Research Database. | BMJ (Clinical research ed.) 20090101 |
| [A multidisciplinary approach of nicotine addiction--the new face of the tabaccology conference. Iaşi, June 25-27, 2009]. | Pneumologia (Bucharest, Romania) 20090101 |
| Practical implementation of varenicline as an aid to smoking cessation in clinical practice. | Pneumologia (Bucharest, Romania) 20090101 |
| Regulation of smoking cessation drugs by the Food and Drug Administration. | Food and drug law journal 20090101 |
| Clinical utility of varenicline for smokers with medical and psychiatric comorbidity. | International journal of chronic obstructive pulmonary disease 20090101 |
| Varenicline: for smoking cessation. | Kathmandu University medical journal (KUMJ) 20090101 |
| Evaluation of cost-utility of varenicline compared with existing smoking cessation therapies in South Korea. | Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research 20090101 |
| Cost-effectiveness of pharmacogenetic testing to tailor smoking-cessation treatment. | The pharmacogenomics journal 20081201 |
| Effect of varenicline on the acute and repeated locomotor responses to nicotine in rats. | Synapse (New York, N.Y.) 20081201 |
| Varenicline-associated acute renal failure. | The Annals of pharmacotherapy 20081201 |
| Possible varenicline-induced paranoia and irritability in a patient with major depressive disorder, borderline personality disorder, and methamphetamine abuse in remission. | Journal of clinical psychopharmacology 20081201 |
| [Drug treatment for smoking and marijuana abuse]. | Revue des maladies respiratoires 20081201 |
| [Specific program for smoking cessation: thus your patients become nonsmokers]. | MMW Fortschritte der Medizin 20081113 |
| Varenicline for tobacco dependence. | The New England journal of medicine 20081106 |
| Lack of a pharmacokinetic interaction between a new smoking cessation therapy, varenicline, and digoxin in adult smokers. | European journal of clinical pharmacology 20081101 |
| The influence of acute varenicline administration on smoking and eating behavior in humans. | Pharmacology, biochemistry, and behavior 20081101 |
| Multimodal techniques for smoking cessation: a review of their efficacy and utilisation and clinical practice guidelines. | International journal of clinical practice 20081101 |
| Smoking cessation in pregnancy. | Expert opinion on drug safety 20081101 |
| Smoking cessation: new ways to quit. | Harvard men's health watch 20081101 |
| Suicidal ideation and varenicline: a possible case of mistaken adverse drug reaction? | The Journal of clinical psychiatry 20081101 |
| Varenicline and smokers with mental illnesses. | Lancet (London, England) 20081004 |
| Nicotinic receptor partial agonists as novel compounds for the treatment of smoking cessation. | Expert opinion on investigational drugs 20081001 |
| Varenicline ameliorates nicotine withdrawal-induced learning deficits in C57BL/6 mice. | Behavioral neuroscience 20081001 |
| Pharmacotherapy for smoking cessation. | Therapeutic advances in respiratory disease 20081001 |
| [Varenicline for smoking cessation]. | Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke 20080911 |
| Neuropsychiatric disturbance after initiation of varenicline in a patient with a history of alcohol abuse and major depression. | American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20080901 |
| Drugs for tobacco dependence. | Treatment guidelines from the Medical Letter 20080901 |
| The risk-benefit balance of varenicline for smoking cessation. | Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 20080901 |
| Varenicline and suicidality: a new era in medication safety surveillance. | Expert opinion on drug safety 20080901 |
| First in class. | Scientific American 20080901 |
| Smoking cessation: the psychiatrist's role. | Journal of psychiatry & neuroscience : JPN 20080901 |
| Varenicline versus transdermal nicotine patch for smoking cessation: results from a randomised open-label trial. | Thorax 20080801 |
| Varenicline efficacy and tolerability in a subject with schizophrenia. | Schizophrenia research 20080801 |
| The place of varenicline in smoking cessation treatment. | Thorax 20080801 |
| Pre-cessation varenicline treatment vs post-cessation NRT: an uneven playing field. | Thorax 20080801 |
| Clinically significant outcomes in smoking cessation. | Thorax 20080801 |
| Tobacco smoking cessation management: integrating varenicline in current practice. | Vascular health and risk management 20080801 |
| Nicotine receptor partial agonists for smoking cessation. | The Cochrane database of systematic reviews 20080716 |
| Pharmacotherapies for smoking cessation: a meta-analysis of randomized controlled trials. | CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne 20080715 |
| Varenicline (Chantix) warnings: risk versus benefit. | The Medical letter on drugs and therapeutics 20080714 |
| Varenicline ameliorates ethanol-induced deficits in learning in C57BL/6 mice. | Neurobiology of learning and memory 20080701 |
| The efficacy and safety of varenicline for smoking cessation using a flexible dosing strategy in adult smokers: a randomized controlled trial. | Current medical research and opinion 20080701 |
| Diffuse exanthema in a patient receiving varenicline. | American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20080701 |
| Clinical inquiries. What are the most effective ways you can help patients stop smoking? | The Journal of family practice 20080701 |
| [Champix not suitable for elderly with depression]. | Lakartidningen 20080701 |
| [Cost effectiveness analysis of varenicline (Champix) for the treatment of smoking in Spain]. | Anales de medicina interna (Madrid, Spain : 1984) 20080701 |
| Updated US smoking cessation guideline advises counseling, combining therapies. | JAMA 20080618 |
| Smoking cessation in pregnancy: why, how, and what next.. | Clinical obstetrics and gynecology 20080601 |
| Pharmacological effects of nicotine on norepinephrine metabolism in rat brown adipose tissue: relevance to nicotinic therapies for smoking cessation. | Toxicologic pathology 20080601 |
| Exacerbation of recurrent depression as a result of treatment with varenicline. | The American journal of psychiatry 20080601 |
| Varenicline-induced mixed mood and psychotic episode in a patient with a past history of depression. | CNS spectrums 20080601 |
| Which drug to be used in smoking cessation? | Polskie Archiwum Medycyny Wewnetrznej 20080601 |
| Varenicline treatment for smokers with schizophrenia: a case series. | The Journal of clinical psychiatry 20080601 |
| Smoking cessation therapy with varenicline. | International journal of chronic obstructive pulmonary disease 20080601 |
| Varenicline as compared to bupropion in smoking-cessation therapy--cost-utility results for Sweden 2003. | Respiratory medicine 20080501 |
| Varenicline may trigger severe hypoglycaemia in Type 1 diabetes. | Diabetic medicine : a journal of the British Diabetic Association 20080501 |
| Empowering dental hygienists: tobacco cessation resources. | International journal of dental hygiene 20080501 |
| Varenicline for smoking cessation. | Drug and therapeutics bulletin 20080501 |
| [The ABC of smoking cessation]. | Medizinische Monatsschrift fur Pharmazeuten 20080501 |
| New kid on the block: Chantix for smoking cessation. | Texas dental journal 20080501 |
| Stat bite: Medicaid coverage of tobacco-dependence treatments. | Journal of the National Cancer Institute 20080402 |
| N-methylation and N-formylation of a secondary amine drug (varenicline) in an osmotic tablet. | Journal of pharmaceutical sciences 20080401 |
| Effect of human renal cationic transporter inhibition on the pharmacokinetics of varenicline, a new therapy for smoking cessation: an in vitro-in vivo study. | Clinical pharmacology and therapeutics 20080401 |
| Effect of varenicline and bupropion SR on craving, nicotine withdrawal symptoms, and rewarding effects of smoking during a quit attempt. | Psychopharmacology 20080401 |
| Human abuse liability of the smoking cessation drug varenicline in smokers and nonsmokers. | Clinical pharmacology and therapeutics 20080401 |
| Clinical pharmacology of nicotine: implications for understanding, preventing, and treating tobacco addiction. | Clinical pharmacology and therapeutics 20080401 |
| Breaking away from a narrow prescribing protocol for medicinal nicotine. | Addiction (Abingdon, England) 20080401 |
| Efficacy and safety of varenicline for smoking cessation. | The American journal of medicine 20080401 |
| Drug addiction: a critical problem calling for novel solutions. | Clinical pharmacology and therapeutics 20080401 |
| Smoking cessation 2008. | IDrugs : the investigational drugs journal 20080401 |
| What's new in clinical pharmacology and therapeutics. | WMJ : official publication of the State Medical Society of Wisconsin 20080401 |
| FDA warns of adverse events linked to smoking cessation drug and antiepileptics. | JAMA 20080312 |
| Comment and reply: A double-blind study evaluating the long-term safety of varenicline for smoking cessation. | Current medical research and opinion 20080201 |
| Hypomania with agitation associated with varenicline use in bipolar II disorder. | The Annals of pharmacotherapy 20080201 |
| Smoking cessation and lung cancer: oncology nurses can make a difference. | Seminars in oncology nursing 20080201 |
| Varenicline: a new pharmaceutical approach to smoking cessation. | Nursing for women's health 20080201 |
| Synthesis, nicotinic acetylcholine receptor binding, and pharmacological properties of 3'-(substituted phenyl)deschloroepibatidine analogs. | Bioorganic & medicinal chemistry 20080115 |
| Cost-effectiveness of varenicline compared with bupropion, NRT, and nortriptyline for smoking cessation in the Netherlands. | Current medical research and opinion 20080101 |
| Varenicline in the routine treatment of tobacco dependence: a pre-post comparison with nicotine replacement therapy and an evaluation in those with mental illness. | Addiction (Abingdon, England) 20080101 |
| An update on therapeutics for tobacco dependence. | Expert opinion on pharmacotherapy 20080101 |
| Smoking cessation--what works? | Australian family physician 20080101 |
| Varenicline versus bupropion SR or placebo for smoking cessation: a pooled analysis. | American journal of health behavior 20080101 |
| Cost-utility analysis of varenicline versus existing smoking cessation strategies using the BENESCO Simulation model: application to a population of US adult smokers. | PharmacoEconomics 20080101 |
| Chantix. | Plastic surgical nursing : official journal of the American Society of Plastic and Reconstructive Surgical Nurses 20080101 |
| Varenicline and its role in smoking cessation. | Preventive cardiology 20080101 |
| Smoking cessation therapy considerations for patients with chronic kidney disease. | Nephrology nursing journal : journal of the American Nephrology Nurses' Association 20080101 |
| Systematic review and meta-analysis of combination therapy for smoking cessation. | Journal of the American Pharmacists Association : JAPhA 20080101 |
| [Not smoking, essential for healthy lungs]. | Pharmazie in unserer Zeit 20080101 |
| Treatment of ataxia and imbalance with varenicline (chantix): report of 2 patients with spinocerebellar ataxia (types 3 and 14). | Clinical neuropharmacology 20080101 |
| Smoking cessation in cardiovascular patients. | Hellenic journal of cardiology : HJC = Hellenike kardiologike epitheorese 20080101 |
| [Pharmacotherapy of smoking cessation with application of nicotine and nicotine free drugs]. | Przeglad lekarski 20080101 |
| Varenicline and adult ADHD. | The Journal of neuropsychiatry and clinical neurosciences 20080101 |
| Varenicline, appetite, and weight reduction. | The Journal of neuropsychiatry and clinical neurosciences 20080101 |
| A reader responds to 'Seven pharmacotherapies do promote smoking abstinence at 6 and 12 months'. | Medscape journal of medicine 20080101 |
| A longer course of varenicline therapy improves smoking cessation rates. | Preventive cardiology 20080101 |
| Which is the best primary medication for long-term smoking cessation--nicotine replacement therapy, bupropion or varenicline? | Expert opinion on pharmacotherapy 20071201 |
| Treatment of tobacco dependence: integrating recent progress into practice. | CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne 20071120 |
| [Varenicline--a new drug for smoking cessation]. | Ugeskrift for laeger 20071119 |
| [New drugs; varenicline]. | Nederlands tijdschrift voor geneeskunde 20071110 |
| Lack of pharmacokinetic and pharmacodynamic interactions between a smoking cessation therapy, varenicline, and warfarin: an in vivo and in vitro study. | Journal of clinical pharmacology 20071101 |
| Smoking cessation: an overview of treatment options with a focus on varenicline. | Pharmacotherapy 20071101 |
| Breaking the ties of nicotine dependence. | The Nurse practitioner 20071101 |
| Interference with smoking-cessation effects of varenicline after administration of immediate-release amphetamine-dextroamphetamine. | Pharmacotherapy 20071001 |
| Smoking cessation: tactics that make a big difference. | The Journal of family practice 20071001 |
| A new medication for the worst addiction. | Current psychiatry reports 20071001 |
| A second varenicline trial. | Current psychiatry reports 20071001 |
| Varenicline as maintenance therapy. | Current psychiatry reports 20071001 |
| Treating tobacco dependence in women. | Journal of women's health (2002) 20071001 |
| The truth about smoking cessation. | The Johns Hopkins medical letter health after 50 20071001 |
| The cost effectiveness of varenicline for smoking cessation. | Managed care interface 20071001 |
| A call to action: new treatment options provide even more reasons to intervene in tobacco dependence. | Nature clinical practice. Cardiovascular medicine 20070901 |
| [Varenicline]. | Revue de l'infirmiere 20070901 |
| An evaluation of the OECD 308 water/sediment systems for investigating the biodegradation of pharmaceuticals. | Environmental science & technology 20070815 |
| Varenicline-induced manic episode in a patient with bipolar disorder. | The American journal of psychiatry 20070801 |
| Exacerbation of schizophrenia by varenicline. | The American journal of psychiatry 20070801 |
| Varenicline: progress in smoking cessation treatment. | Expert opinion on pharmacotherapy 20070801 |
| Optimizing on smoke free legislation making the most of the opportunity. | British journal of community nursing 20070801 |
| Smoking cessation: lessons learned from clinical trial evidence. | Current opinion in cardiology 20070701 |
| Rationale, pharmacology and clinical efficacy of partial agonists of alpha4beta2 nACh receptors for smoking cessation. | Trends in pharmacological sciences 20070701 |
| Varenicline: the newest agent for smoking cessation. | American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20070701 |
| The pharmacist's role in tobacco cessation: overview and introduction to the series. | American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20070701 |
| New non-nicotine drug to help smoking cessation efforts. | Nursing times 20070601 |
| Why choose varenicline (chantix) for smoking cessation treatment? | Issues in mental health nursing 20070601 |
| Smoking cessation update. | South Dakota medicine : the journal of the South Dakota State Medical Association 20070601 |
| [New smoking cessation preparations unsuitable in mental disorders]. | Lakartidningen 20070601 |
| How well does the new drug varenicline work for people who want to stop smoking? | The Harvard mental health letter 20070601 |
| A randomized, placebo-controlled trial of varenicline, a selective alpha4beta2 nicotinic acetylcholine receptor partial agonist, as a new therapy for smoking cessation in Asian smokers. | Clinical therapeutics 20070601 |
| Efficacy and tolerability of varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, in a 12-week, randomized, placebo-controlled, dose-response study with 40-week follow-up for smoking cessation in Japanese smokers. | Clinical therapeutics 20070601 |
| Confirmatory factor analyses and reliability of the modified cigarette evaluation questionnaire. | Addictive behaviors 20070501 |
| Comment: Oral varenicline for smoking cessation. | The Annals of pharmacotherapy 20070401 |
| A double-blind study evaluating the long-term safety of varenicline for smoking cessation. | Current medical research and opinion 20070401 |
| An employer-based cost-benefit analysis of a novel pharmacotherapy agent for smoking cessation. | Journal of occupational and environmental medicine 20070401 |
| Pharmacological profile of the alpha4beta2 nicotinic acetylcholine receptor partial agonist varenicline, an effective smoking cessation aid. | Neuropharmacology 20070301 |
| [The path from cigarettes--with support it works better]. | Medizinische Monatsschrift fur Pharmazeuten 20070301 |
| [Varenicline--a new drug for smoking cessation]. | Medizinische Monatsschrift fur Pharmazeuten 20070301 |
| The most addictive drug, the most deadly substance: smoking cessation tactics for the busy clinician. | Primary care 20070301 |
| [Giving up smoking is crucial for COPD patients]. | MMW Fortschritte der Medizin 20070222 |
| Ligands selective for alpha4beta2 but not alpha3beta4 or alpha7 nicotinic receptors generalise to the nicotine discriminative stimulus in the rat. | Psychopharmacology 20070201 |
| Impact of pharmacometric reviews on new drug approval and labeling decisions--a survey of 31 new drug applications submitted between 2005 and 2006. | Clinical pharmacology and therapeutics 20070201 |
| Drug approvals. | The Nurse practitioner 20070201 |
| Varenicline for smoking cessation. | Expert review of neurotherapeutics 20070201 |
| Varenicline: new treatment with efficacy in smoking cessation. | Drugs of today (Barcelona, Spain : 1998) 20070201 |
| [Drug of the month. Varenicline (Champix)]. | Revue medicale de Liege 20070201 |
| [Champix has become a registered drug]. | Orvosi hetilap 20070128 |
| Nicotine receptor partial agonists for smoking cessation. | The Cochrane database of systematic reviews 20070124 |
| Mechanism of varenicline (clinical ramifications): electron transfer and oxidative stress. | Medical hypotheses 20070101 |
| Oral varenicline for smoking cessation. | The Annals of pharmacotherapy 20070101 |
| Non-nicotinic therapies for smoking cessation. | Annual review of pharmacology and toxicology 20070101 |
| A clinical imperative: assisting patients who smoke to reduce their risk of cardiovascular disease. | Preventive cardiology 20070101 |
| Smoking cessation pharmacotherapy--nicotine and non-nicotine preparations. | Preventive cardiology 20070101 |
| Maximizing smoking cessation in clinical practice: pharmacologic and behavioral interventions. | Preventive cardiology 20070101 |
| [Tobacco use prevention and cessation in the dental practice]. | Schweizer Monatsschrift fur Zahnmedizin = Revue mensuelle suisse d'odonto-stomatologie = Rivista mensile svizzera di odontologia e stomatologia 20070101 |
| Varenicline: a selective alpha4beta2 nicotinic acetylcholine receptor partial agonist approved for smoking cessation. | Cardiology in review 20070101 |
| [Varenicline (Champix)]. | Journal de pharmacie de Belgique 20070101 |
| Alcohol history and smoking cessation in nicotine replacement therapy, bupropion sustained release and varenicline trials: a review. | Alcohol and alcoholism (Oxford, Oxfordshire) 20070101 |
| Kicking butts: smoking cessation update. | Missouri medicine 20070101 |
| [Varenicline: an aid to smoking cessation therapy]. | Revue medicale de Bruxelles 20070101 |
| [Varenicline--a new chance for smokers?]. | Przeglad lekarski 20070101 |
| Efficacy of varenicline for smoking cessation. | JAMA 20061206 |
| Multiple-dose pharmacokinetics of the selective nicotinic receptor partial agonist, varenicline, in healthy smokers. | Journal of clinical pharmacology 20061201 |
| Trials that matter: varenicline: a designer drug to help smokers quit. | Annals of internal medicine 20061121 |
| Pharmacokinetics, safety, and tolerability after single and multiple oral doses of varenicline in elderly smokers. | Journal of clinical pharmacology 20061101 |
| New prescription drug available to help smokers stop. | Mayo Clinic health letter (English ed.) 20061001 |
| Varenicline is a partial agonist at alpha4beta2 and a full agonist at alpha7 neuronal nicotinic receptors. | Molecular pharmacology 20060901 |
| Single-dose pharmacokinetics of varenicline, a selective nicotinic receptor partial agonist, in healthy smokers and nonsmokers. | Journal of clinical pharmacology 20060901 |
| New weapon to curb smoking: no more excuses to delay treatment. | Archives of internal medicine 20060801 |
| Smoking cessation with varenicline, a selective alpha4beta2 nicotinic receptor partial agonist: results from a 7-week, randomized, placebo- and bupropion-controlled trial with 1-year follow-up. | Archives of internal medicine 20060801 |
| Efficacy and safety of the novel selective nicotinic acetylcholine receptor partial agonist, varenicline, for smoking cessation. | Archives of internal medicine 20060801 |
| Varenicline (Chantix) for tobacco dependence. | The Medical letter on drugs and therapeutics 20060801 |
| Varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs sustained-release bupropion and placebo for smoking cessation: a randomized controlled trial. | JAMA 20060705 |
| Efficacy of varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs placebo or sustained-release bupropion for smoking cessation: a randomized controlled trial. | JAMA 20060705 |
| Effect of maintenance therapy with varenicline on smoking cessation: a randomized controlled trial. | JAMA 20060705 |
| Varenicline for smoking cessation: definite promise, but no panacea. | JAMA 20060705 |
| Varenicline. | Nature reviews. Drug discovery 20060701 |
| The neurobiological basis for partial agonist treatment of nicotine dependence. | International journal of clinical practice 20060501 |
| The neurobiological basis for partial agonist treatment of nicotine dependence: varenicline. | International journal of clinical practice 20060501 |
| Molecule of the Month. Varenicline tartrate. | Drug news & perspectives 20060401 |
| Pharmacologic interventions for smoking cessation. | Critical care nursing clinics of North America 20060301 |
| FDA speeds smoking cessation drug review. | JAMA 20060208 |
| Metabolism and disposition of varenicline, a selective alpha4beta2 acetylcholine receptor partial agonist, in vivo and in vitro. | Drug metabolism and disposition: the biological fate of chemicals 20060101 |
| New drugs: varenicline tartrate, insulin glulisine, and insulin detemir. | Journal of the American Pharmacists Association : JAPhA 20060101 |
| Varenicline: a review of its use as an aid to smoking cessation therapy. | CNS drugs 20060101 |
| Effectiveness of smoking cessation therapies: a systematic review and meta-analysis. | BMC public health 20060101 |
| [New tobacco dependence drug: Varenicline, partial agonist of alpha4beta2 acetylcholine-nicotine receptors]. | Casopis lekaru ceskych 20060101 |
| The FDA approves new drug for smoking cessation. | FDA consumer 20060101 |
| Smoking cessation efficacy and safety of varenicline, an alpha4beta2 nicotinic receptor partial agonist. | The Journal of cardiovascular nursing 20060101 |
| Varenicline (CHANTIX): a stop-smoking pill. | ORL-head and neck nursing : official journal of the Society of Otorhinolaryngology and Head-Neck Nurses 20060101 |
| 3,5-Bicyclic aryl piperidines: a novel class of alpha4beta2 neuronal nicotinic receptor partial agonists for smoking cessation. | Bioorganic & medicinal chemistry letters 20051115 |
| [Medication for ending tobacco dependency. Current state]. | Atencion primaria 20050630 |
| Varenicline: an alpha4beta2 nicotinic receptor partial agonist for smoking cessation. | Journal of medicinal chemistry 20050519 |
| Revealing the multidimensional framework of the Minnesota nicotine withdrawal scale. | Current medical research and opinion 20050501 |
| Direct PCO2 measurements in the dorso-bronchial gas of awake Peking ducks: evidence for a physiological role of the neopulmo in respiratory gas exchanges. | Comparative biochemistry and physiology. A, Comparative physiology 19751201 |